You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 227 No. 12, March 25, 1974 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Duration and Death in Systemic Lupus Erythematosus

An Analysis of 249 Cases

Edmund L. Dubois, MD; Michael Wierzchowiecki, MD; Mavis B. Cox; John M. Weiner, DrPH

JAMA. 1974;227(12):1399-1402.


Abstract

Of 491 patients with systemic lupus erythematosus (SLE), 249 (51%) are known dead. From 1950 to 1955, 15 of 57 patients (26%) died of central nervous system (CNS) damage and an equal number died of uremia.

High-dosage corticosteroid therapy for CNS involvement was introduced in 1956. From 1956 to 1962, only 11 of 100 patients died of CNS involvement and 36% of the patients died of uremia. During the past ten years, with high-dose corticosteroid therapy, dialysis, and renal transplantation, only 7 of 92 patients (8%) died of CNS damage and 14% of the patients died of uremia. Death from infections, vascular complications, and malignant neoplasms occurred more frequently. The changes were significant (P<.0001).

Black patients did not have a more malignant course than others. The median time from diagnosis to death in 79 blacks was 3.5 years; this was identical in 170 other patients.



Author Affiliations

From the Department of Medicine, Section of Rheumatic Disease and Immunology, University of Southern California School of Medicine, Los Angeles.


Footnotes

Reprint requests to 2025 Zonal Ave, Los Angeles 90033 (Dr. Dubois).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Flaxseed in Lupus Nephritis: A Two-Year Nonplacebo-Controlled Crossover Study
Clark et al.
J. Am. Coll. Nutr. 2001;20:143-148.
ABSTRACT | FULL TEXT  

Epidemiology of cardiovascular disease in systemic lupus erythematosus
Aranow and Ginzler
Lupus 2000;9:166-169.
ABSTRACT  

Survival analysis of 306 European Spanish patients with systemic lupus erythematosus
Blanco et al.
Lupus 1998;7:159-163.
ABSTRACT  

SLE mortality in an oriental population
Koh et al.
Lupus 1997;6:27-31.
ABSTRACT  

Suicide in Patients with Systemic Lupus Erythematosus: A Clinical Analysis of Seven Suicidal Patients
Matsukawa et al.
Lupus 1994;3:31-35.
ABSTRACT  

Parkinson-Like Symptoms as a Manifestation of Systemic Lupus Erythematosus
Miyoshi et al.
Lupus 1993;2:199-201.
ABSTRACT  

Systemic Lupus Erythematosus in Males: Analysis of Clinical and Laboratory Features
Olcay Aydintug et al.
Lupus 1992;1:295-298.
ABSTRACT  

Cardiac Rupture Following Acute Myocardial Infarction in Systemic Lupus Erythematosus: Case Report
Takayanagi et al.
ANGIOLOGY 1990;41:662-666.
ABSTRACT  

Ancrod in Systemic Lupus Erythematosus With Thrombosis: Clinical and Fibrinolysis Effects
Dosekun et al.
Arch Intern Med 1984;144:37-42.
ABSTRACT  

Subarachnoid Spinal Hemorrhage in a Case of Systemic Lupus Erythematosus
Fody et al.
Arch Neurol 1980;37:173-174.
ABSTRACT  

Ibuprofen-Induced Meningitis in Systemic Lupus Erythematosus
Widener and Littman
JAMA 1978;239:1062-1064.
ABSTRACT  

Corticosteroid Treatment in Systemic Lupus Erythematosus: Survival Studies
Urman and Rothfield
JAMA 1977;238:2272-2276.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.